Spotlight Medical Emerges from Stealth to Tackle the Critical Issue of Inadequate Cancer Treatments
27 June 2024 - 7:38AM
Business Wire
Spotlight Medical, spinoff of Institut Curie, proudly announced
its official launch. This innovative startup aims to transform
cancer treatment using advanced artificial intelligence (AI),
leveraging a unique technology developed by researchers and
clinicians from Institut Curie, Mines Paris – PSL, and Inserm, over
several years.
Founded by a physician, an AI researcher, and an entrepreneur,
Spotlight Medical addresses the critical issue of inadequate cancer
treatments. Many patients face over- or undertreatment, leading to
reduced survival rates and unnecessary side effects. The founders
believe that patient data holds untapped potential, which AI can
harness to significantly improve patient care by identifying the
most appropriate treatment for each individual.
"Our incredibly powerful and innovative technology has unlocked
unprecedented capabilities in tailoring cancer treatments,” said
Sylvain Berlemont, co-founder and CEO of Spotlight Medical. “The
potential impact on patient survival rates and quality of life is
immense, heralding a new era in personalized cancer treatment. Our
mission is to make it a reality—for patients and their
families.”
Spotlight Medical’s clinical AI tests extract meaningful
biological information from patient data within a secure and
regulated framework. This data predicts treatment response
efficacy, guiding oncologists in selecting the most suitable
options for their patients. The technology is versatile, capable of
handling various cancer types, with the first test focusing on a
specific use case to be announced soon.
The strategic alliance between Institut Curie and Spotlight
Medical combines clinical expertise, extensive clinical data,
advanced technology, and industrial resources to accelerate the
development and implementation of innovative cancer solutions.
“The launch of Spotlight Medical, based on the pioneer work
conducted in Institut Curie’s lab and leveraged by Institut Curie’s
clinical data, is further proof of our ability to develop
high-potential entrepreneurial projects. Spotlight Medical is
paving the way for a major, innovative, and promising improvement
of patient treatments,” said Cécile Campagne, PhD, Director of
Institut Curie’s Technology Transfer Office.
About Spotlight Medical
Spotlight Medical is a precision medicine company striving to
free all patients from cancer through a better understanding of
each patient’s unique disease. We develop advanced AI tests that
enhance treatment selection by leveraging decades of patient data.
This ensures personalized and effective care for each individual,
significantly improving patient outcomes and quality of life. By
closely collaborating with physicians, we create impactful tests
that address critical unmet clinical needs, opening a new era in
cancer care.
For more information, visit spotlightmedical.com and follow us
on LinkedIn and Twitter.
About Institut Curie
Institut Curie, France’s leading cancer center, combines an
internationally-renowned research center with a cutting-edge
hospital group, treating all types of cancer, including the rarest.
Founded in 1909 by Marie Curie, Institut Curie has 3 sites (Paris,
Saint-Cloud and Orsay) with over 3,700 researchers, physicians and
health professionals working on its 3 missions: treatment, research
and teaching. A private foundation with public utility status,
Institut Curie is authorized to accept donations and bequests, and
thanks to the support of its donors, is able to accelerate
discoveries and improve patient treatment and quality of life. Find
out more: www.curie.fr, Twitter, Facebook, LinkedIn, Instagram
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240626294795/en/
Spotlight Medical - Bruno Arabian - +33 06 87 88 47 26 -
barabian@ulysse-communication.com Institut Curie - Elsa
Champion - +33 07 64 43 09 28 - elsa.champion@curie.fr